Who is sponsoring IDENTIFY?

IDENTIFY is sponsored by British Urology Researchers in Surgical Training.

What condition does IDENTIFY study?

IDENTIFY studies Urothelial Carcinoma.

What is the status of IDENTIFY?

IDENTIFY is currently COMPLETED.

Last reviewed 2021-11-11 · How we verify

Investigation and Detection of Urological Neoplasia in Patients Referred With Suspected Urinary Tract Cancer: (IDENTIFY)

NCT03548688 COMPLETED

Bladder cancer is common in the UK and can kill. A common sign of bladder cancer is blood in the urine (haematuria). GPs will refer to a specialist (Urologist) for further investigation of haematuria if they suspect cancer. Hospitals often have a 'blanket' approach for investigating patients with haematuria. IDENTIFY will collect data on patients having these tests across the UK and internationally, looking at any trends with an aim to create a personalised diagnostic approach for each patient. The data will give patients the ability to make informed decisions, as well as reducing unnecessary and potentially harmful tests.

Details

Lead sponsor	British Urology Researchers in Surgical Training
Status	COMPLETED
Enrolment	11059
Start date	Thu Dec 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Jan 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Urothelial Carcinoma

Countries

United Kingdom